Please provide your email address to receive an email when new articles are posted on . Men prescribed long-acting testosterone undecanoate injections had a higher adherence to therapy at 1 year ...
NORTHBROOK, Ill., Nov. 30, 2021 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (Clarus) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by ...
Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — Three new testosterone therapies offer innovative drug delivery options for men with hypogonadism ...
Testosterone has been used for substitution therapy in testicular and hypothalamopituitary diseases for almost six decades, with injectable testosterone esters and implanted testosterone pellets being ...
Injectable testosterone esters and transdermal testosterone gels have generally been assumed to be equally safe and effective forms of testosterone-replacement therapy for male hypogonadism. Now, ...